Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qiling Tablets
- Development stage
- Preclinical
- Lead developer
- Shanghai University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qiling Tablets (芪灵片) is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Shanghai University of Traditional Chinese Medicine in collaboration with Chengji (Zhuhai Hengqin) Pharmaceutical Technology. It is currently in preclinical development for the treatment of lumbar disc herniation. As an oral herbal tablet, it is part of the Shanghai TCM Science and Technology Innovation Project. The formulation is designed to address the symptoms and underlying pathology of lumbar disc displacement, likely through anti-inflammatory and analgesic pathways common to TCM musculoskeletal therapies.
- Other names
- 芪灵片Qiling Tablets
Beyond the preview
Go deeper on Qiling Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qiling Tablets.